classic
swine
fever
viru
csfv
porcin
parvoviru
ppv
highli
contagi
pathogen
result
enorm
econom
loss
pig
industri
worldwid
vaccin
play
import
role
diseas
control
research
seek
improv
vaccin
could
induc
antivir
immun
respons
csfv
ppv
mucos
system
level
simultan
studi
genet
engin
lactobacillu
strain
coexpress
csfvspecif
cytotox
lymphocyt
ctl
epitop
antigen
ppv
develop
immunopotenti
capac
oral
vaccin
pig
analyz
data
demonstr
absenc
adjuv
recombin
lactobacillu
strain
effici
stimul
mucos
system
csfvspecif
ctl
respons
protect
pig
csfv
challeng
moreov
serum
igg
mucos
iga
induc
pig
immun
oral
recombin
lactobacillu
strain
show
neutral
effect
ppv
infect
result
suggest
recombin
lactobacillu
microecolog
agent
may
valuabl
compon
strategi
develop
vaccin
csfv
ppv
fig
inhibit
viral
plaqu
format
sera
intestin
lavag
fluid
b
prepar
pig
oral
immun
sera
intestin
lavag
fluid
collect
day
first
immun
valu
sampl
express
maximum
reduct
number
plaqu
result
mean
standard
error
mean
classic
swine
fever
viru
csfv
member
genu
pestiviru
famili
flavivirida
small
envelop
singlestrand
rna
viru
natur
condit
pig
suscept
speci
viru
caus
acut
subacut
chronic
diseas
porcin
parvoviru
ppv
character
member
autonom
parvovirus
major
caus
reproduct
failur
swine
result
earli
embryon
death
fetal
death
stillbirth
delay
return
estru
enorm
econom
loss
pig
industri
caus
two
pathogen
therefor
develop
effici
vaccin
csfv
ppv
simultan
practic
signific
vaccin
csfv
import
role
humor
immun
respons
investig
particularli
term
neutral
antibodi
instanc
pig
immun
recombin
viru
express
csfv
protein
protect
csfv
challeng
case
immun
anim
recombin
viru
express
csfv
protein
fail
induc
detect
neutral
antibodi
wherea
anim
protect
lethal
csfv
infect
indic
virusspecif
lymphocyt
particip
protect
immun
respons
csfv
current
cellular
immun
respons
especi
product
virusspecif
cytotox
lymphocyt
ctl
receiv
attent
potenti
role
develop
effici
epitop
vaccin
csfv
sever
csfvspecif
tcell
epitop
identifi
epitop
peptid
khkvrnevmvhwfdd
locat
amino
acid
residu
csfv
nonstructur
protein
could
advantag
harbor
csfvspecif
helper
tcell
epitop
ctl
epitop
could
elicit
tcell
respons
therefor
peptid
promis
candid
epitop
vaccin
control
csf
among
vaccin
ppv
inactiv
vaccin
one
often
use
prevent
control
infect
humor
immun
respons
particular
neutral
antibodi
play
import
role
therefor
develop
effici
vaccin
induc
antibodi
neutral
ppv
infect
desir
protein
ppv
encompass
major
antigen
domain
therefor
regard
promis
candid
immunogen
capac
induc
neutral
antibodi
moreov
csfv
ppv
initi
infecti
cycl
mucos
surfac
although
parenter
vaccin
usual
effici
elicit
protect
immun
respons
parenter
rout
gener
fail
stimul
mucos
immun
respons
effici
prevent
pathogen
enter
bodi
via
mucosa
therefor
effici
protect
mucos
invas
requir
develop
new
vaccin
induc
protect
mucos
immun
respons
infect
point
respect
mucos
immun
proven
effect
approach
thu
necessari
develop
effici
safe
antigen
vector
could
trigger
mucos
system
immun
respons
one
promis
approach
reli
use
live
vehicl
lactobacillu
strain
possess
mani
properti
make
attract
candid
antigen
carrier
present
mucosa
compound
pharmaceut
interest
particular
immunomodul
vaccin
lactobacilli
well
known
benefici
effect
health
human
anim
addit
lactobacilli
surviv
colon
intestin
tract
furthermor
induc
nonspecif
immunoadjuv
effect
potenti
live
recombin
lactobacillu
deliv
heterolog
antigen
immun
system
investig
suggest
feasibl
use
lactobacilli
safe
oral
vaccin
present
studi
recombin
lactobacillu
strain
coproduc
csfvspecif
ctl
epitop
ppv
protein
develop
use
plasmid
express
vector
immunogen
oral
vaccin
use
elicit
antivir
mucos
system
immun
respons
pig
analyz
data
show
oral
immun
recombin
strain
abl
induc
csfvspecif
ctl
respons
csfv
challeng
neutral
antibodi
ppv
infect
pig
indic
new
strategi
develop
csfv
ppv
vaccin
bacteria
plasmid
virus
lactobacillu
casei
atcc
plasmid
kindli
gift
j
seeger
nizo
netherland
csfv
strain
shimen
ppv
strain
kindli
suppli
china
institut
veterinari
drug
control
ppv
strain
preserv
veterinari
depart
northeast
agricultur
univers
harbin
peopl
republ
china
construct
recombin
lactobacillu
strain
dna
manipul
perform
accord
standard
procedur
genom
dna
ppv
strain
propag
swine
testicular
st
cell
extract
sodium
dodecyl
sulfat
sd
proteas
k
sigma
method
gene
ppv
obtain
pcr
primer
upper
lower
contain
sali
site
xhoi
site
underlin
respect
gene
clone
salixhoi
fragment
plasmid
gener
gene
encod
csfv
peptid
synthes
pcr
assay
primer
upper
lower
contain
bamhi
site
sali
site
respect
overlap
base
pcr
product
clone
bamhisali
fragment
give
rise
bamhixhoi
fragment
subclon
gener
fig
subsequ
recombin
lactobacillu
construct
electropor
accord
method
describ
previous
result
transform
identifi
enzym
digest
sequenc
colon
capac
recombin
strain
intestin
tract
recombin
strain
label
fluoresc
dye
carboxyfluorescein
diacet
succinimidyl
ester
cfdase
sigma
brief
group
three
pig
week
old
fed
approxim
cfuml
cfdaselabel
recombin
strain
control
two
group
three
pig
fed
either
cfdaselabel
l
casei
atcc
steril
pb
day
oral
administr
duodenum
jejunum
ileum
colon
pig
extract
complianc
ethic
guidelin
individu
section
cut
longitudin
visibl
residu
food
particl
fecal
materi
remov
prior
examin
cfdaselabel
lactobacilli
differ
intestin
section
enumer
epic
elit
flow
sorter
excit
wavelength
argon
laser
sort
sens
flow
cell
kpa
pressur
upon
excit
nm
flow
cytomet
bd
cfdase
give
maxim
emiss
signal
green
fluoresc
nm
data
record
fcsexpress
file
format
use
coulter
epic
elit
softwar
analyz
use
winmdi
fulli
cfdaselabel
lactobacilli
use
posit
control
unlabel
lactobacilli
use
neg
control
protein
express
western
blot
l
casei
atcc
harbor
cultiv
overnight
mr
medium
supplement
xylos
overnight
cultur
centrifug
g
min
supernat
collect
concentr
time
use
ultrafreecl
pbcc
centrifug
filter
unit
millipor
analyz
polyacrylamid
gel
electrophoresi
page
protein
transfer
onto
nitrocellulos
membran
invitrogen
blot
nonspecif
proteinbind
site
block
overnight
block
solut
tiangen
beij
china
immunoblot
develop
use
mous
serum
anticsfv
peptid
mous
serum
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
sigma
use
immunolabel
band
visual
chemiluminesc
substrat
reagent
pierc
accord
manufactur
instruct
immun
cultur
centrifug
cell
pellet
resuspend
steril
suspens
buffer
concentr
cfuml
vaccin
group
pig
month
old
matern
antibodi
csfv
ppv
obtain
harbin
tianxiang
pig
farm
harbin
peopl
republ
china
five
miniatur
pig
dd
haplotyp
obtain
huaibei
beij
peopl
republ
china
immun
oral
cfuml
recombin
strain
per
kg
control
group
immun
equival
dose
pb
pig
per
group
immun
protocol
administ
two
consecut
day
day
booster
immun
given
day
second
booster
given
day
cytotoxictcel
assay
five
vaccin
miniatur
pig
dd
haplotyp
kept
specificpathogenfre
spf
condit
bled
day
first
immun
peripher
blood
mononuclear
cell
pbmc
separ
use
densiti
gradient
centrifug
describ
previous
time
intestin
tissu
obtain
laparotomi
lamina
propria
lymphocyt
prepar
previous
describ
immun
cell
seed
roundbottom
micropl
concentr
ml
rpmi
supplement
fetal
bovin
serum
fb
sigma
restimul
tissu
cultur
infect
dose
tcid
csfv
shimen
per
well
day
use
effector
cell
max
cell
kind
gift
g
h
zhang
northeast
agricultur
univers
harbin
china
infect
csfv
shimen
h
use
target
cell
cytotox
assay
brief
ml
target
cell
label
ci
na
cro
amersham
h
co
wash
resuspend
cultur
medium
ctl
peptid
ml
noninfect
chromiumlabel
max
cell
incub
g
csfv
peptid
co
incub
h
csfvinfect
peptideload
target
cell
cell
per
well
ad
variou
concentr
effector
cell
rang
cell
per
well
experi
perform
triplic
cultur
cell
centrifug
g
min
incub
co
h
chromium
level
supernat
measur
use
cobra
autogamma
model
gamma
counter
packard
percentag
specif
cytolyt
activ
calcul
follow
cpm
experiment
releas
cpm
spontan
releas
cpm
total
releas
cpm
spontan
releas
mockinfect
neg
peptideload
target
cell
serv
control
furthermor
enzymelink
immunospot
elispot
assay
use
detect
peptidespecif
gamma
interferon
secret
cell
describ
previous
minor
modif
pbmc
incub
irrelev
peptid
serv
neg
control
csfv
challeng
experi
pig
immun
csfv
shimen
propag
porcin
kidney
cell
co
incub
day
viru
titer
determin
endpoint
dilut
titrat
cell
accord
method
describ
previous
group
pig
oral
fed
recombin
pb
control
challeng
oral
lethal
dose
csfv
strain
shimen
tcid
anim
pig
examin
daili
diseas
symptom
fever
defin
rectal
temperatur
pig
surviv
rate
record
day
challeng
serum
sampl
collect
variou
time
point
csfv
challeng
viru
titer
serum
sampl
determin
endpoint
dilut
titrat
elisa
analysi
antibodi
level
pig
sera
prepar
day
first
immun
store
requir
time
intestin
lavag
fluid
pig
collect
prepar
enzymelink
immunosorb
assay
elisa
previous
describ
polystyren
microtit
plate
coat
overnight
ppv
strain
propag
st
cell
elisa
plate
wash
three
time
pb
contain
tween
satur
skim
milk
h
serum
intestin
lavag
sampl
dilut
bovin
serum
albumin
bsa
use
primari
antibodi
incub
h
plate
wash
anoth
three
time
bound
antibodi
detect
use
hrpconjug
goat
antipig
iga
igg
dilut
sigma
follow
color
develop
use
tetramethylbenzidin
tmb
substrat
absorb
measur
nm
neutral
abil
antibodi
ppv
obtain
immun
pig
serum
igg
mucos
iga
sampl
obtain
pig
immun
oral
day
first
immun
evalu
use
plaqu
reduct
assay
determin
abil
neutral
ppv
infect
sampl
obtain
pig
fed
pb
use
control
brief
nondilut
sampl
prepar
plate
ppv
adjust
tcid
l
viru
diluent
concentr
hank
balanc
salt
solut
bovin
serum
albumin
ph
ad
cell
plate
mix
incub
h
l
st
cell
use
viru
infect
ad
antibodyviru
mixtur
incub
co
incub
day
overlay
medium
discard
well
wash
three
time
steril
pb
ph
stain
crystal
violet
solut
differ
number
plaqu
form
cell
receiv
differ
treatment
examin
level
signific
student
test
analysi
varianc
colon
recombin
pig
oral
given
cfdaselabel
differ
intestin
section
isol
day
oral
immun
follow
collect
cfdaselabel
abil
recombin
colon
swine
intestin
determin
flowcytometr
analysi
data
show
fig
express
plasmid
construct
gene
ppv
amplifi
pcr
csfvspecif
ctl
epitop
gene
synthes
pcr
success
clone
salixhoi
bamhisali
fragment
gener
respect
fusion
gene
subclon
bamhixhoi
fragment
plasmid
give
rise
sp
secret
signal
peptid
plasmid
use
secret
antigen
origin
lactococc
protein
combin
xylos
operon
promot
vol
oral
immun
csfv
ppv
recombin
strain
abl
colon
intestin
tract
includ
duodenum
jejunum
ileum
colon
colon
abil
similar
l
casei
atcc
tabl
supernat
recombin
strain
cultur
overnight
mr
contain
xylos
concentr
time
analyz
sdspage
western
blot
result
sdspage
show
fusion
protein
express
secret
supernat
shown
fig
immunoreact
band
detect
supernat
use
mous
serum
fig
lane
anticsfv
peptid
mous
antiserum
lane
primari
antibodi
wherea
band
interest
control
strain
lane
induct
specif
cytotox
respons
recombin
strain
vivo
capac
recombin
strain
stimul
mucos
system
cytotox
respons
csfv
analyz
vivo
pbmc
lamina
propria
lymphocyt
vaccin
miniatur
pig
obtain
day
first
immun
restimul
vitro
csfv
shimen
cytotox
activ
test
evalu
lysi
peptideload
target
max
cell
label
chromium
mockinfect
negativepeptideload
target
cell
serv
control
cytolyt
respons
peptid
max
cell
observ
mucos
tissu
fig
also
system
level
fig
indic
abl
stimul
csfvspecif
ctl
respons
vivo
order
confirm
reactiv
csfvspecif
cell
csfv
antigen
pbmc
obtain
vaccin
challeng
infect
test
abil
produc
upon
stimul
viru
peptid
elispot
assay
data
show
high
number
cell
observ
pbmc
infect
pig
stimul
peptid
none
unvaccin
anim
detect
circul
virusspecif
cell
fig
releas
peptid
sequenc
specif
spot
observ
incub
pbmc
irrelev
peptid
atcc
recombin
protect
pig
csfv
challeng
order
analyz
capac
recombin
strain
protect
pig
csfv
infect
vaccin
pig
challeng
oral
lethal
dose
tcid
anim
csfv
strain
shimen
day
first
immun
pig
immun
oral
pb
use
control
result
demonstr
effect
protect
csfv
challeng
perform
day
vaccin
pig
control
group
pig
develop
sever
clinic
symptom
csf
viral
challeng
euthan
moribund
day
challeng
infect
fig
addit
surviv
pig
fulli
protect
addit
viral
challeng
perform
day
indic
abl
induc
longterm
protect
immun
csfv
vaccin
group
pig
show
viru
challengeinduc
fever
peak
day
postchalleng
day
challeng
pig
recov
clinic
csfv
clinic
sign
control
group
develop
sever
symptom
csf
high
fever
peak
day
viral
infect
fig
littl
viru
detect
vaccin
group
surviv
pig
day
challeng
indic
effici
viral
clearanc
tabl
immun
respons
induc
pig
local
mucos
system
immun
respons
investig
measur
iga
level
intestin
lavag
sampl
igg
level
serum
pig
oral
immun
respect
level
iga
igg
determin
via
elisa
use
ppv
strain
coat
antigen
shown
fig
substanti
differ
p
mucos
iga
level
vaccin
group
control
group
prior
immun
oral
immun
elicit
antigenspecif
mucos
iga
respons
second
booster
high
level
iga
obtain
intestin
lavag
fluid
vaccin
pig
show
substanti
differ
p
rel
control
group
moreov
first
booster
pig
oral
immun
exhibit
prompter
stronger
serum
igg
respons
signific
level
antibodi
observ
control
group
pig
p
fig
ppvneutral
abil
antibodi
plaqu
reduct
assay
perform
test
ppvneutral
abil
antibodi
collect
pig
oral
immun
sampl
serum
antibodi
igg
mucos
antibodi
iga
obtain
vaccin
pig
day
first
immun
neutral
abil
express
maximum
result
demonstr
presenc
iga
igg
cultur
medium
confer
statist
signific
p
abil
neutral
ppv
infect
maximum
inhibit
rate
nearli
igg
fig
iga
fig
indic
could
induc
neutral
antibodi
ppv
develop
viru
vaccin
antigen
deliveri
vehicl
play
critic
role
effect
vaccin
pathogen
sever
strategi
develop
deliv
exogen
antigen
cytosol
protein
peptid
antigen
deliv
associ
appropri
adjuv
eg
incomplet
freund
adjuv
liposom
iscom
complet
freund
adjuv
particul
form
link
latex
microspher
effici
stimul
cellular
humor
immun
respons
recombin
live
vector
includ
attenu
virus
vaccinia
viru
mengo
viru
pseudorabi
viru
bacteria
bacillu
lactobacillu
salmonella
listeria
also
shown
induc
protect
immun
respons
vivo
contrast
among
avail
approach
stimul
effici
mucos
respons
use
lactobacilli
carrier
deliv
vaccin
antigen
constitut
one
success
strategi
present
csf
control
stamp
outmethod
vaccin
combin
two
erad
strategi
inevit
result
enorm
econom
loss
though
tradit
csfv
avirul
vaccin
particular
lapin
c
strain
csfv
success
use
sever
countri
prevent
control
csf
use
tradit
csfv
avirul
vaccin
ban
sinc
european
union
mainli
infect
vaccin
field
virus
distinguish
serolog
therefor
design
new
efficaci
vaccin
protect
anim
csfv
pursu
previou
studi
shown
cellular
immun
respons
especi
product
csfvspecif
ctl
repres
import
defens
mechan
elimin
cell
infect
csfv
thu
work
focu
develop
induc
ctl
respons
vaccin
csfv
ppv
fairli
ubiquit
viru
multipli
normal
swine
intestin
without
caus
clinic
sign
initi
ppv
infect
mainli
occur
mucosa
intestin
therefor
elicit
effici
immun
respons
system
also
mucos
level
vaccin
highli
desir
would
repres
signific
advantag
prevent
ppv
infect
via
mucosa
goal
achiev
vaccin
administ
mucos
rout
studi
lactobacillu
casei
select
live
oral
vaccin
vehicl
deliv
csfvspecif
ctl
epitop
protein
induc
protect
antivir
immun
respons
csfv
ppv
pig
fusion
protein
success
express
determin
sdspage
western
blot
antigen
properti
compromis
recogn
specif
antiserum
moreov
recombin
plasmid
show
good
segreg
structur
stabil
l
casei
atcc
follow
serial
subcultur
viru
vaccin
research
one
critic
step
identif
immun
respons
immun
defens
stimul
antigen
subunit
infect
host
investig
concentr
role
humor
immun
respons
csfvinfect
anim
cellular
immun
respons
often
ignor
studi
cellular
immun
respons
csfv
natur
host
utmost
import
understand
interact
pathogen
swine
immun
system
basi
develop
vaccin
control
csfv
infect
work
capac
stimul
csfvspecif
ctl
respons
vitro
vivo
analyz
absenc
adjuv
csfvspecif
ctl
respons
detect
intestin
mucos
tissu
miniatur
swine
vaccin
oral
recombin
strain
measur
ctl
activ
detect
nonimmun
anim
indic
effector
cell
abl
recogn
natur
process
epitop
infecti
viru
kill
peptid
target
cell
result
suggest
local
mucos
immun
induc
recombin
strain
particular
induct
local
cytotox
lymphocyt
respons
may
control
csfv
replic
within
local
tissu
prior
system
dissemin
also
analyz
whether
mucos
immun
strain
could
induc
antigenspecif
ctl
system
signific
cytolyt
respons
observ
result
consist
previous
describ
ctl
activ
studi
due
promis
result
vitro
protect
capac
test
pig
immun
oral
recombin
strain
effect
protect
csfv
challeng
induct
csfvspecif
major
histocompat
complex
mhc
class
irestrict
ctl
control
group
pig
develop
sever
clinic
symptom
csf
viral
challeng
euthan
moribund
addit
abl
induc
longterm
protect
immun
csfv
iga
predomin
antibodi
mucos
surfac
produc
local
level
exce
immunoglobulin
play
import
role
prevent
invas
pathogen
thu
effici
ppv
oral
vaccin
induc
specif
immun
respons
system
level
also
mucos
level
particular
mucos
iga
respons
viru
invas
via
mucosa
evalu
immunogen
pig
found
mucos
system
immun
respons
could
effici
elicit
intragastr
administr
experi
test
protect
gravid
pig
ppv
challeng
difficult
order
confirm
efficaci
induc
antibodi
inhibit
viru
determin
whether
intestin
lavag
fluid
sera
could
inhibit
infect
st
cell
plaqu
reduct
neutral
assay
serum
intestin
sampl
collect
vaccin
pig
demonstr
statist
signific
inhibit
would
first
step
give
proof
principl
protect
efficaci
target
speci
moreov
avail
live
oral
vaccin
colon
intestin
tract
import
desir
studi
investig
colon
potenti
pig
intestin
show
recombin
strain
abl
persist
colon
intestin
tract
similar
nativ
counterpart
l
casei
atcc
probiot
bacterium
long
resid
time
intestin
tract
would
prolong
potenti
benefici
health
effect
conclus
result
clearli
demonstr
recombin
strain
construct
studi
provid
safe
effici
vaccin
induc
csfvspecif
ctl
csfv
ppvneutral
activ
probiot
effect
l
casei
atcc
suggest
promis
express
deliveri
system
present
differ
ctl
epitop
viral
antigen
immun
system
